← Back to Clinical Trials
Recruiting NCT07932418

NCT07932418 Assessment of the Oblique Sandwich Osteotomy for Augmentation of Posterior Atrophic Mandible

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07932418
Status Recruiting
Phase —
Sponsor Ain Shams University
Condition Atrophic Mandible
Study Type INTERVENTIONAL
Enrollment 10 participants
Start Date 2026-08-01
Primary Completion 2026-12-01

Eligibility & Interventions

Sex All sexes
Min Age 42 Years
Max Age 50 Years
Study Type INTERVENTIONAL
Interventions
oblique sandwich osteotomy augmentation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 10 participants in total. It began in 2026-08-01 with a primary completion date of 2026-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Rehabilitation of the partially or totally edentulous mandible with implant supported prosthesis has become a common practice in the last few decades. Local conditions of the edentulous ridges may be unfavorable for dental implant placement, where sufficient bony support in both the horizontal and vertical dimensions is the foundation of any successful oral rehabilitation with dental implants. Challenges include the resorpative changes of the alveolar ridge after tooth extractions and the hard tissue deficits due to chronic periodontal disease or congenitally missing teeth. Neoplasm, osteomyelitis, cysts or trauma can also compromise the situation. All these factors require the oral implantologist to create using regenerative techniques sufficient hard tissue support at the appropriate site before or during dental implant installation. Multiple bone grafting materials and techniques have been used to reconstruct the partially dentate and edentulous posterior mandibular ridges with high rates of success, these techniques include block onlay grafting technique, guided bone regeneration using membranes or meshes and distraction osteogenesis. The selection of the optimal technique depends on various factors, including the degree of the defect, the grafted bone substitute available, the medical condition of the patient and also the skill and experience of the operator. The aim of this study is to evaluate the alveolar bone volume by the CBCT after performing oblique sandwich osteotomy in conjunction with interpositional autogenous bone grafting in the atrophied posterior mandible.

Eligibility Criteria

Inclusion Criteria: * Partially edentulous patients with moderate to severe posterior atrophic mandibular ridges, * Sufficient alveolar bone width for implant placement (at least 7 mms), * A native alveolar bone height above the mandibular alveolar canal till the alveolar crest (measuring from 5 to 9 mms), * Adequate inter-arch space, * The site of the graft is free from any pathologic lesion as cyst, infection or tumor. Exclusion Criteria: * The patients suffering from any systemic and metabolic disease that may affect normal healing of bone and soft tissue as diabetes or osteoporosis

Contact & Investigator

Central Contact

nehal Shobair lecturer, PhD

✉ nehalshobair@dent.asu.edu.eg

📞 010171181794

Frequently Asked Questions

Who can join the NCT07932418 clinical trial?

This trial is open to participants of all sexes, aged 42 Years or older, up to 50 Years, studying Atrophic Mandible. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07932418 currently recruiting?

Yes, NCT07932418 is actively recruiting participants. Contact the research team at nehalshobair@dent.asu.edu.eg for enrollment information.

Where is the NCT07932418 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07932418 clinical trial?

NCT07932418 is sponsored by Ain Shams University. The trial plans to enroll 10 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology